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While the pathophysiology and clinical significance of arterial calcifications have been 
studied extensively, minimal focus has been placed on venous calcification deposition. 
In this study, we evaluated the association between calcium deposition in human saphe-
nous vein (HSV), endothelial function, and patient demographic risk factors. Fifty-four 
HSV segments were collected at the time of coronary artery bypass graft (CABG) sur-
gery. The presence or absence of calcium deposits was visualized using the Von Kossa 
staining method. Endothelial function was determined by measuring muscle tissue con-
traction with phenylephrine and relaxation with carbachol in a muscle bath. Additional 
segments of vein underwent histologic evaluation for preexisting intimal thickness and 
extracellular matrix (ECM) deposition. Patient demographics data were obtained through 
our institution’s electronic medical record, with patient consent. Calcium was present 
in 16 of 54 samples (29.6%). Veins with calcium deposits had significantly greater 
intimal-to-medial thickness ratios (p  =  0.0058) and increased extracellular collagen 
deposition (p = 0.0077). Endothelial relaxation was significantly compromised in calcified 
veins vs. those without calcium (p = 0.0011). Significant patient risk factors included 
age (p = 0.001) and preoperative serum creatinine (p = 0.017). Calcified veins can be 
characterized as having endothelial dysfunction with increased basal intimal thickness 
and increased ECM deposition. Patient risk factors for calcium deposits in veins were 
similar to those for arteries, namely, advanced age and kidney disease. Further studies 
are needed to determine the effect of preexisting vein calcification on short- and long-
term graft patency.
Keywords: calcification, demographics, intimal thickness, endothelial dysfunction, endothelial-dependent 
relaxation, vein graft failure, human saphenous vein
inTrODUcTiOn
Saphenous vein is the most commonly used bypass conduit for coronary artery and peripheral arte-
rial bypass surgery. However, recent large prospective studies have indicated that graft failure rates 
remain high [39% of lower extremity bypass grafts and 45% of coronary artery bypass grafts (CABGs) 
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will fail within 12–18  months, Project of Ex vivo Vein Graft 
Engineering via Transfection (PREVENT) III and PREVENT 
IV trials, respectively] (1, 2). The leading cause of graft failure 
is intimal hyperplasia (IH), a complex process involving the 
migration, proliferation, and phenotypic modulation of vascular 
smooth muscle cells (VSMCs) (3).
Preexisting disease in the saphenous vein has been implicated 
as a contributing factor to the development of IH and graft failure. 
The most frequently encountered lesion found on pre-bypass 
vein histology is intimal thickening (4). Our lab has previously 
published an association between preexisting intimal thickness 
and endothelial dysfunction (5). Marin et al. reported more fre-
quent peripheral bypass graft failure with use of thicker-walled 
saphenous vein (6). Additional characteristics in morphology 
may contribute to the baseline quality of a saphenous vein graft.
Studies conducted to determine the quality of arterial conduits 
for CABG (most commonly the internal mammary and radial 
arteries) have evaluated vessel wall thickness and vessel wall 
calcification (7–9). In general, the pathophysiology and clinical 
relevance of arterial calcification is much better established than 
for venous calcification. Arterial calcification is broadly catego-
rized by its vascular layer of involvement. Medial calcification, 
or Monckeberg sclerosis, is generally associated with metabolic 
derangement, such as in type 2 diabetes mellitus, end-stage renal 
disease, and hyperphosphatemia, and results in reduced arterial 
compliance and elasticity (10–12). The subsequent widening 
of pulse pressure is an independent predictor of hypertension, 
stroke, and all-cause mortality. In contrast, intimal calcification, 
a component of atherosclerosis, is more often associated with 
inflammatory states, such as in hyperlipidemia, hypertension, 
and smoking. These calcified plaques contribute to the narrowing 
of the arterial lumen and increase the risk of ischemic events. 
Coronary artery calcification of either type is an independent 
predictor of cardiovascular mortality and is used as a surrogate 
end point for clinical trials to determine the efficacy of medica-
tions and lifestyle modification (13). Since saphenous vein is the 
most widely used conduit for CABG, a study of vein calcification 
will help to understand how it affects the quality of the vein as a 
conduit and whether it contributes to the development of IH and 
subsequent graft failure.
In this study, we evaluated saphenous vein segments, obtained 
at the time of CABG surgery, for preexisting calcification. The 
presence or absence of calcium deposits was then correlated with 
other histologic markers of venous pathology (intimal thickness 
and ECM deposition), physiologic function, and patient demo-
graphics. We hypothesized that the presence of calcium deposits 
would be associated with concurrent venous pathology and 
physiologic dysfunction. In addition, we anticipated that known 
patient risk factors for arterial calcification would also predict the 
presence of venous calcification.
MaTerials anD MeThODs
Procurement of human saphenous  
Veins (hsVs)
Human saphenous vein samples were collected at the time of har-
vest for CABG surgery. This study was carried out in accordance 
with the recommendations of the Institutional Review Boards 
of Vanderbilt University Medical Center and the VA Tennessee 
Valley Healthcare System in Nashville, TN, USA with written 
informed consent from all subjects. All subjects gave written 
informed consent in accordance with the Declaration of Helsinki. 
The protocol was approved by the Institutional Review Boards 
of Vanderbilt University Medical Center and the VA Tennessee 
Valley Healthcare System in Nashville, TN, USA. Segments of 
vein were harvested from 54 patients by either open or endo-
scopic technique, according to surgeon preference. Samples were 
immediately stored in sterile, heparinized (10 U/mL) PlasmaLyte 
(Baxter Healthcare Corporation, Deerfield, IL, USA) solution 
(140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq 
chloride, 27 mEq acetate, and 23 mEq gluconate) without further 
manipulation. Tissue with obvious forceps crush injury and areas 
containing a tributary orifice were discarded. The remaining 
tissue was then cut into sequential, 2 mm rings, fixed with 10% 
buffered formalin, and sent to the Translational Pathology Shared 
Resource at Vanderbilt University Medical Center for histologic 
preparation of 5  µm sequential sections embedded in paraffin. 
Additional fresh tissue rings were cut and suspended in a muscle 
bath to evaluate physiologic properties.
evaluation of calcium Deposits
Vein ring sections were stained using the Von Kossa method to 
observe calcification. Paraffin was melted and removed from each 
slide. Slides were then incubated in 5% silver nitrate solution for 
2 h under a 50 W light (control slide was incubated in water). Slides 
were then washed with 5% sodium thiosulfate, counterstained 
with hematoxylin, dehydrated, and mounted. Tissue images were 
obtained and digitalized using the Zeiss Axiovert 200 M micro-
scope at 20× magnification. Veins were then grouped as having 
no calcium deposits (non-calcified) or having some amount of 
calcium deposits present (calcified).
intimal Thickness Measurement
Verhoeff-Van Gieson (VVG) stain was used to visualize the vein 
intima and media. A total of eight intimal width measurements 
were made from each image, two from each quadrant at 20×. 
Vein intimal thickness for each sample was defined as the mean 
of these measurements. The medial thickness was obtained in a 
similar fashion at 5× magnification, and the intimal/medial ratio 
(IMR) was calculated.
extracellular Matrix (ecM) Deposition 
analysis
Extracellular matrix deposition was examined using a Movat 
pentachrome stain, which gives collagen a yellow-brown hue. 
The collagen amount was quantified using Photoshop C5’s pixel 
count feature at a fuzziness level of 50%. The pixel count was 
standardized as a ratio to the overall image pixel number. At least 
four pictures from each vein sample were analyzed and the ratios 
averaged.
Physiologic Measurements of hsVs
Details regarding the use of muscle baths to determine vascular 
physiologic function have been previously described (5). 
FigUre 1 | calcification in human saphenous veins (hsVs). HSV rings 
were stained with the Von Kossa stain to detect calcium deposits. (a) Von 
Kossa stained veins without calcification. (B) Veins that stained positive for 
calcification contained black, speckled area (black arrow, 20×) that indicated 
calcium deposits.
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Briefly, 1  mm rings from the tissue were cut, weighed, and 
measured lengthwise using calipers. Rings were suspended 
in an organ bath containing a bicarbonate buffer (120  mM 
NaCl, 4.7 mM KCl, 1.0 mM MgSO4, 1.0 mM NaH2PO4, 10 mM 
glucose, 1.5 mM CaCl2, and 25 mM Na2HCO3, pH 7.4), equili-
brated with 95% oxygen and 5% carbon dioxide at 37°C. Each 
ring was progressively stretched to its optimal resting tension 
(approximately 1 g) that would produce a maximal response to 
contractile agonists, then maintained at the resting tension and 
equilibrated for a minimum of 2 h. Force measurements were 
obtained using a Radnoti Glass Technology (Monrovia, CA, 
USA) force transducer (159901A) interfaced with a Powerlab 
data acquisition system and Chart software (ADInstruments, 
Colorado Springs, CO, USA). The rings were contracted with 
110mM potassium chloride (KCl) to determine functional 
viability. Samples that failed to contract with KCl were con-
sidered non-functional and removed from further testing. 
Functional rings were equilibrated in the bicarbonate buffer for 
30 min and were then contracted with phenylephrine (10−6M), 
and the endothelium-dependent relaxation was measured 
with carbachol (5 × 10−7M), a cholinergic agonist that causes 
tissue relaxation in the presence of intact endothelium. The 
force generated was measured and converted to stress {(105 N/
m2) =  force (g) × 0.0987/area, where area is equal to the wet 
weight [(mg)/length (mm at maximal length)] divided by 
1.055} using each specimen’s weight and length. The percent-
age of endothelial-dependent relaxation was calculated as the 
change in stress compared to the maximal tension induced by 
phenylephrine as previously described (14).
Patient Demographic collection
Patient demographics and lab values were obtained using insti-
tutional electronic medical records with patient consent. The 
data collected included demographic characteristics, laboratory 
results, comorbidities, and medications listed at the time of 
surgery. Patients were grouped by the presence or absence of 
preexisting saphenous vein calcification.
statistical analysis
Bivariate analysis of all variables was conducted to screen 
for those factors associated with calcification (via Pearson 
chi-squared test). Factors that trended with calcification were 
included in logistic multivariate stepwise regression models. 
Variables significant upon multivariate analysis were deemed 
independent predictors of the end points, at a level of statistical 
significance of p < 0.05. As all variables included in multivariate 
analyses had a variance inflation factor of <1.8, collinearity was 
not statistically considered. Measures of central tendency were 
reported as mean ± SD. Statistical analysis was performed with 
JMP Pro 11 (Cary, NC, USA) and GraphPad Prism (La Jolla, 
CA, USA).
resUlTs
A total of 54 vein segments were collected and analyzed for 
the presence of calcification. Forty of these samples underwent 
additional histologic analysis to evaluate preexisting intimal 
thickness and ECM deposition. The remaining 14 segments 
were excluded due to improper histologic processing. All 54 
vein segments underwent physiologic testing on muscle baths. 
Of these, 39 were viable based on the KCl contraction chal-
lenge. Finally, we obtained baseline demographic data on 53 
patients.
Presence of calcium associated with 
Preexisting intimal Thickness
Calcium deposits were present in 16 of 54 vein samples (29.6%) 
(Figure  1). Calcified veins had greater preexisting intimal 
thickness, expressed IMR, compared to non-calcified veins 
(0.214 ± 0.028 vs. 0.134 ± 0.013; p = 0.006) (Figure 2).
calcification associated with additional 
Markers of Vascular Pathology
We examined whether calcified veins would exhibit other 
histologic markers of pathology. ECM collagen deposition is 
a component of the IH response (15). Calcified veins revealed 
more ECM collagen deposition, expressed as a pixel ratio, overall 
(0.210 ± 0.029 vs. 0.111 ± 0.020; p = 0.0077). It was notable that 
collagen deposition appeared to localize with calcium with areas 
of increased calcium and collagen density within the tissue ring 
(Figure 3).
Venous calcification inversely correlated 
with endothelial-Dependent relaxation
We then examined whether calcification affected the endothelial 
function of a vein. One reliable method of assessing vessel func-
tion is endothelial relaxation. Vein rings were contracted with 
phenylephrine (10−6 M) and treated with carbachol (5 × 10−7 M). 
In the presence of an intact, functioning endothelium, carbachol 
induces relaxation of the vessel. Thirty-nine vein samples were 
determined to be viable, and the percentage of carbachol-induced 
relaxation was calculated. The endothelial relaxation of calcified 
veins was lower in comparison to non-calcified veins (3.3 ± 0.9 
vs. 18.4 ± 3.0%, p = 0.0011, Figure 4).
FigUre 4 | calcification and endothelial relaxation of human 
saphenous vein. The vein segments were equilibrated in a muscle bath and 
contracted with phenylephrine (10−6 M) and relaxed with carbachol (10−7 M) 
to measure the endothelial relaxation. The endothelial relaxation of veins with 
calcification was significantly lower compared to non-calcified veins 
(p = 0.0011, n = 12–28).
FigUre 3 | increased extracellular matrix (ecM) deposition in human 
saphenous veins with calcification. The amount of ECM deposition was 
evaluated using the Movat pentachrome stain. The yellow areas (black arrow) 
represent collagen in non-calcified vein (a) and calcified vein (B).  
(c) Quantitation of collagen. The calcified veins had a significantly higher 
amount of ECM deposition compared to non-calcified veins (p = 0.0182, 
n = 10–12).
FigUre 2 | intimal thickening in human saphenous veins (hsVs) 
[Verhoeff-Van gieson (VVg) stain]. HSVs were fixed, sectioned, and 
stained with VVG and imaged with light microscopy. Representative images 
of non-calcified vein with thin intima [(a), 20×] and calcified vein with thick 
intima [(B), 20×]. White line indicates the thickness of intima. IEL, internal 
elastic lamina, M, media. (c) The intima to media (I/M) ratio of calcified veins 
compared to non-calcified veins was significantly higher (*p = 0.0058, 
n = 12–28).
4
Pedigo et al. Calcification Associated with Endothelial Dysfunction
Frontiers in Surgery | www.frontiersin.org February 2017 | Volume 4 | Article 6
Patient age and Kidney Function Predict 
Venous calcifications
Patient data were collected and paired with each vein sample. 
Patient groups were defined as those without evidence of 
venous calcium (non-calcified) and those with any amount 
of calcium (calcified). Using the Pearson chi-squared test to 
determine which factors were associated with calcification the 
following had a strong association with calcification: age, ever 
smoker, chronic kidney disease (CKD), preoperative serum 
creatinine (SCr), and glomerular filtration rate. After running 
a stepwise regression fit using minimum Bayesian information 
criterion as a stopping rule, age and preoperative SCr were 
entered into the model. A nominal logistic regression of these 
two variables yielded significance for both variables in a multi-
variate analysis. Preoperative SCr had an area under the curve 
of 0.81, p = 0.001, and a unit odds ratio of 405.7, age had an 
area under the curve of 0.78, p = 0.003, and a unit odds ratio of 
1.12 (Figure 5; Table 1).
DiscUssiOn
This is the first study, to our knowledge, to describe venous 
calcification in terms of concurrent vein pathology, endothelial 
function, and patient risk factors. In this study, ~30% of the veins 
analyzed had calcium deposits. Veins with calcium had higher 
intimal thickness (Figure  2), increased extracellular collagen 
deposition (Figure  3), and decreased endothelial relaxation 
(Figure  4). Significant patient risk factors included age and 
preoperative SCr (Table 1).
Once believed to be a passive process of metabolic derange-
ment, vascular calcification is now thought to result from dedif-
ferentiation of VSMC to an osteoblast phenotype in response to 
injury. Osteoblasts responsible for bone calcification produce a 
primarily collagen-based ECM that is subsequently mineralized 
with hydroxyapatite, a calcium phosphate (16). Arterial calcifica-
tion studies have demonstrated a similar pattern of collagen and 
calcium deposition (17). In the present study, we observed cal-
cium deposits within areas of increased ECM collagen with more 
collagen per area in calcified veins. This suggests the presence 
of cell-mediated osteogenesis by osteoblast-type VSMC within 
veins as in arterial and bone calcium deposition.
TaBle 1 | Demographic data on patients with calcium deposits or no 
calcium deposits within a saphenous vein sample.
Patient characteristics non-calcified 
vein (n = 33)
calcified vein (n = 12) p
Age 60.5 ± 1.8 72.3 ± 2.9 0.001
Male sex 85(%) 75(%) 0.456
Caucasian 88(%) 100(%) 0.200
BMI 30.2 ± 1.5 26.4 ± 2.3 0.173
smoking status
Current smoker 42.4(%) 16.7(%) 0.101
Former smoker 39.4(%) 33.3(%) 0.456
Non-smoker 9.1(%) 41.6(%) 0.018
comorbidities
Diabetes mellitus 36.4(%) 58.3(%) 0.764
Hypertension 90.9(%) 91.7(%) 0.938
COPD 9.1(%) 16.7(%) 0.485
Hyperlipidemia 84.8(%) 66.7(%) 0.186
Chronic kidney disease 21.2(%) 58.3(%) 0.017
Medications
ARB 6.1(%) 25(%) 0.077
ACEi 60.6(%) 50(%) 0.268
Statins 87.9(%) 91.7(%) 0.700
Nitrates 18.2(%) 33.3(%) 0.290
Beta-blockade 87.9(%) 83.3(%) 0.302
CCA 18.2(%) 8.3(%) 0.432
ASA 90.9(%) 91.7(%) 0.486
Other antiplatelet (%) (%)
Insulin
laboratory values
Total cholesterol 145.9± 164.3± 0.335
HDL 36.6± 35.11± 0.702
LDL 98.3± 84.4± 0.307
Triglycerides 165.2± 180.6± 1.000
Hg A1C 6.3± 6.3± 0.970
Serum creatinine 0.9± 1.3± 0.001
Bold font indicates the significant data.
FigUre 5 | receiver operator curve using age and preoperative 
creatinine. In a multivariate logistic regression, age and preoperative 
creatinine were used to predict calcification of human saphenous veins 
resulting in an area under the curve of 0.78 and 0.81, respectively.
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The pathological deposition of vascular ECM facilitates not 
only mineralization but also the migration of VSMCs from 
media to intima, a key underlying process of IH (18). Chitalia 
et al. reported on the coexistence of IH and vascular calcification 
within brachial and radial arteries of CKD patients (19) while 
Janda et al. concluded that intimal thickness within the carotid 
artery predicted the presence and severity of calcification (20). 
Our study found a strong association (r2 = 0.184) between cal-
cium and intimal thickness within the saphenous vein as well. 
This is of particular importance in assessing vein quality prior to 
arterial bypass as preexisting intimal thickness in veins predicts 
bypass graft failure (21).
The ideal venous bypass conduit has a functioning, intact 
endothelium, the primary regulator of vascular tone, and vessel 
wall hemostasis (22). The loss of endothelial function predisposes 
the vessel to vasospasm, platelet aggregation, and IH. In this study, 
we found that the presence of venous calcification predicted 
reduced endothelial-dependent relaxation.
The temporal organization of events cannot be concluded 
from these data. It is likely that an injurious venous environment 
related to cardiovascular risk factors causes loss of endothelial 
regulation and VSMC dedifferentiation. This may in turn lead to 
IH and calcium deposition. It is also possible that vein calcifica-
tion preceded the development of IH as can be seen in postphle-
bitic vein segments or alternatively that endothelial dysfunction 
related to venous reflux was the primary event with subsequent 
development of the observed morphological changes. The precise 
sequence of events in a particular patient or group of patients 
may be heterogeneous. Sessa et al. demonstrated that saphenous 
vein endothelial function was reduced in diabetics, smokers, 
and patients with hypertension (23), while age, diabetes, and 
end-stage renal disease (ESRD) have long been associated with 
the development of arterial calcification (24). Not surprisingly, 
risk factors for saphenous vein calcification in our study were 
older age and elevated preoperative SCr. While smoking status, 
ESRD, and hypertension did not reveal a significant association 
with vein calcification, we suspect a larger sample size would 
ultimately reveal a trend mirroring arterial calcification risk 
factors.
There are several limitations with this study. The sample size 
was relatively small. Only acute variables were examined, and 
further studies with a larger sample size are needed to draw 
conclusions regarding venous calcification and long-term bypass 
patency rates. The innate variability between samples when using 
human tissue can be vast. The sections of vein analyzed were not 
implanted and, thus, may not represent the histology and func-
tion of grafted tissue. Further efforts using imaging modalities 
such as vein graft duplex US may allow for longitudinal assess-
ment of calcification and assessment of its long-term effects on 
patency.
cOnclUsiOn
The results of this study demonstrated that preexisting calcifica-
tion in saphenous vein is a marker of poor conduit quality. HSVs 
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with calcification can be characterized as having increased intimal 
thickness, increased ECM deposition, and reduced endothelial-
dependent relaxation. Calcified saphenous vein is more common 
in older patients and those with reduced kidney function. Further 
studies are needed to determine if long-term graft patency rates 
are affected by preexisting vein calcification.
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